2017
DOI: 10.1159/000479474
|View full text |Cite
|
Sign up to set email alerts
|

Portal Vein Embolization: History and Current Indications

Abstract: Portal vein embolization (PVE) was first adapted for patients undergoing major hepatectomy for hepatocellular carcinoma (HCC). In these patients, PVE caused hypertrophy of the unaffected liver and increased the volumetric ratio of future liver remnant (FLR) to total liver volume. 99mTechnetium-galactosyl human serum albumin (99mTc-GSA) scintigraphy revealed that PVE also induced a shift in hepatic function from the embolized part to the nonembolized part of the liver. Various hepatobiliar… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
12
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(12 citation statements)
references
References 21 publications
0
12
0
Order By: Relevance
“…Since the first report in 1986, PVE has progressively become the gold standard for inducing liver hypertrophy with satisfying safety and efficacy[ 31 ]. Initially described by laparotomy, the portal system access is now obtained by percutaneous puncture of the portal vein.…”
Section: Portal Vein Embolizationmentioning
confidence: 99%
“…Since the first report in 1986, PVE has progressively become the gold standard for inducing liver hypertrophy with satisfying safety and efficacy[ 31 ]. Initially described by laparotomy, the portal system access is now obtained by percutaneous puncture of the portal vein.…”
Section: Portal Vein Embolizationmentioning
confidence: 99%
“…Optimization techniques of FLR function such as portal vein embolization (PVE) [25], portal vein ligation (PVL) in two-stage hepatectomy [26], and associating liver partition and PVL for staged hepatectomy (ALPPS) [27] created a new situation with regional heterogeneity of liver function, where conventional CT volumetry cannot exert the ability to appropriately divide the liver function measured as a whole, such as K ICG and LiMAx, into the FLR part and the resection part. Nuclear imaging technology is expected to offer a solution to this issue.…”
Section: Evaluation Of Regional Heterogeneity Of Liver Functionmentioning
confidence: 99%
“…There have been numerous review articles about PVE; however, articles specific for HCC remain limited and all of them mainly discussed the PVE procedure and liver regeneration effect. [35][36][37] In this review, we will summarize the role of PVE for HCC with special attention to oncological effects.…”
Section: Ta B L E 1 Long-term Outcome After Hepatectomy For Hepatocellular Carcinoma Patients With or Without Portal Vein Embolizationmentioning
confidence: 99%